An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)
Clinical trial NCT01196780 · TERMINATED
Trial details
- NCT number
- NCT01196780
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2010-02-01
- Primary completion
- 2015-10-01
- Enrollment
- 1240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.